Antje van Lessen

443 total citations
18 papers, 322 citations indexed

About

Antje van Lessen is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Antje van Lessen has authored 18 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Immunology and 6 papers in Hematology. Recurrent topics in Antje van Lessen's work include CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (4 papers). Antje van Lessen is often cited by papers focused on CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Immunotherapy and Immune Responses (4 papers). Antje van Lessen collaborates with scholars based in Germany, United States and Croatia. Antje van Lessen's co-authors include Stefan Serke, D. Huhn, Ulrike Schneider, Bernd Dörken, Antonio Pezzutto, Jörg Westermann, Anne Flörcken, Joachim Kopp, Michael Hummel and Philipp le Coutre and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Antje van Lessen

17 papers receiving 308 citations

Peers

Antje van Lessen

IMMUN

ONCOL

HEMAT

PFM

Paula Savola Finland

Hans G. Drexler Germany

Maria J. Carnicer Spain

Lisa Christiansson Sweden

Andrea N. Marcogliese United States

Jill Weisenbach United States

S. Goldberg United States

Vojkan Susulic United States

Emily Y. Jen United States

Athalia R. Pyzer United States

Paula Savola Finland

Antje van Lessen

148 ×0.9

IMMUN

81 ×0.6

ONCOL

62 ×0.6

61 ×0.8

HEMAT

51 ×0.9

PFM

Citations per year, relative to Antje van Lessen Antje van Lessen (= 1×) peers Paula Savola

Countries citing papers authored by Antje van Lessen

Since Specialization

Citations

This map shows the geographic impact of Antje van Lessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje van Lessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje van Lessen more than expected).

Fields of papers citing papers by Antje van Lessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje van Lessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje van Lessen. The network helps show where Antje van Lessen may publish in the future.

Co-authorship network of co-authors of Antje van Lessen

This figure shows the co-authorship network connecting the top 25 collaborators of Antje van Lessen. A scholar is included among the top collaborators of Antje van Lessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje van Lessen. Antje van Lessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Flörcken, Anne, Antje van Lessen, Theis H. Terwey, et al.. (2013). Anti-leukemia T cells in AML. Human Vaccines & Immunotherapeutics. 9(6). 1200–1204. 5 indexed citations

Flörcken, Anne, Joachim Kopp, Antje van Lessen, et al.. (2013). Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer. Human Vaccines & Immunotherapeutics. 9(6). 1217–1227. 27 indexed citations

Schabath, Richard, Richard Ratei, Andrea Stroux, et al.. (2013). Peripheral blood sCD3⁻CD4⁺T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma. Hematological Oncology. 32(1). 16–21. 25 indexed citations

Flörcken, Anne, Joachim Kopp, Kamran Movassaghi, et al.. (2012). Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.. Journal of Clinical Oncology. 30(15_suppl). e15053–e15053. 4 indexed citations

Flörcken, Anne, Antje van Lessen, Werner Hopfenmüller, et al.. (2011). Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma. Anti-Cancer Drugs. 23(3). 298–302. 16 indexed citations

Westermann, Jörg, Anne Flörcken, Gerald Willimsky, et al.. (2010). Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study. Gene Therapy. 18(4). 354–363. 15 indexed citations

Neubauer, Angela, et al.. (2008). Einfluß der Methode auf das Ergebnis der Bestimmung von T-Zellsubpopulationen. DMW - Deutsche Medizinische Wochenschrift. 114(11). 414–416.

Westermann, Jörg, Joachim Kopp, Antje van Lessen, et al.. (2007). Vaccination with autologous non‐irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia. British Journal of Haematology. 137(4). 297–306. 34 indexed citations

Westermann, Jörg, Antje van Lessen, Gökben Baskaynak, et al.. (2005). Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia‐reactive T cells in patients with chronic myeloid leukaemia. British Journal of Haematology. 132(1). 32–35. 6 indexed citations

10.

Westermann, Jörg, Georg Maschmeyer, Antje van Lessen, Bernd Dörken, & Antonio Pezzutto. (2005). CD52 Is Not a Promising Immunotherapy Target for Most Patients with Multiple Myeloma. International Journal of Hematology. 82(3). 248–250. 6 indexed citations

11.

Westermann, Jörg, Antje van Lessen, Gökben Baskaynak, et al.. (2005). Simultaneous Cytokine Analysis by Cytometric Bead Array (CBA) Allows More Sensitive Detection of Leukemia-Reactive T Cells in Patients with Chronic Myeloid Leukemia.. Blood. 106(11). 2879–2879. 1 indexed citations

12.

Westermann, Jörg, Joachim Kopp, Antje van Lessen, et al.. (2004). Dendritic Cells Vaccination in BCR/ABL-Positive Chronic Myeloid Leukemia - Final Results of a Phase I/II Study.. Blood. 104(11). 2934–2934. 4 indexed citations

13.

Serke, Stefan, Antje van Lessen, Michael Hummel, et al.. (2000). Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Cytometry. 42(3). 180–187. 28 indexed citations

14.

Serke, Stefan, Antje van Lessen, & D. Huhn. (1998). Quantitative fluorescence flow cytometry: A comparison of the three techniques for direct and indirect immunofluorescence. Cytometry. 33(2). 179–187. 60 indexed citations

15.

Schneider, Ulrike, Antje van Lessen, D. Huhn, & Stefan Serke. (1997). Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. British Journal of Haematology. 97(1). 56–64. 62 indexed citations

16.

Blasczyk, Rainer, et al.. (1996). Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing. Human Immunology. 45(2). 117–123. 10 indexed citations

17.

Blasczyk, Rainer, Antje van Lessen, N. Schwella, D. Huhn, & Abdulgabar Salama. (1995). A novel HLA-DR13 allele (DRB1∗1314) identified by single-strand conformation polymorphism analysis and confirmed by direct sequencing. Human Immunology. 43(4). 309–312. 9 indexed citations

18.

Serke, Stefan, et al.. (1989). Binding of mitogenic plant lectins to human lymphocytes. Journal of Immunological Methods. 121(2). 231–235. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact